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Cefepime is a fourth-generation cephalosporin 
presenting a wider antibacterial spectrum than 
third-generation cepahlosporins, and decreased 
susceptibility to β-lactam hydrolysis. Cefepime 
can be used for infections that are resistant to old 
generation cephalosporins, and for septicemy, as 
well as respiratory, urinary, intra-abdominal, and 
cutaneous infections. Cefepime is considered a 
broad spectrum drug, and shows an excellent 
activity against Escherichia coli, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, 
Enterococcus cloacae, Staphylococcus aureus 
and Estreptococos spp. (Barradell, Bryson, 
1994). 
 
The objective of the present work was to 
investigate the correlation between the kinetic 
variables, and the volume of milk production, 
with and without a local inflammatory reaction 
induced by subcutaneous implants of a device for 
collecting tissue fluid. 
 
Ten healthy goats, with an average somatic cell 
counting of 299.000±193.000 cells/ml of milk 
(mean±SD) were used, and manually milked 
twice a day. Each animal was subcutaneously 
implanted with six devices, similar to cages, of a 
inert material, measuring 10cm long by 1,5cm 
wide, with closed ends, and 40% of perforation 
in the surface.  
 
Samples of blood and tissue fluid were obtained 
once a week after the implantation of the 
collecting devices, during eight weeks. In order 
to assess the organisms reaction to the implant, 
total protein and albumin concentrations were 
determined by biuret reaction, and by method of 
dye binding using bromosulfoftalein. 
 
The antibiotic cefepime was administered by 
intravenous (IV; right jugular vein), and by 
intramuscular (IM; semitendinosus muscle) 
route, once a week, with single doses of 20mg/kg 
of body weight. Blood samples were collected 
from all the animals at 0:10, 0:15, 0:30, 1, 2, 3, 4, 
5, 6, 8, and 12 hours after drug administration. 
Milk sampling, of 1ml, followed the same 
schedule, but started at 15 minutes after drug 
administration. The blood samples were clotted, 
followed by a centrifugation at 1000g for 5min, 
to separate the serum. The samples were then 
stored in sterilized recipients, at –18oC, until 
analyzed. Antibiotic was detected by a biological 
method based on Bacillus stearothermophilus 
var. calidolactis (Lennette, 1987). 
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The kinetic analysis was done by calculation of 
the areas under the curves (AUC) using a 
trapezoidal method, and the results were used to 
estimate de bioavailability (f) [f= 
AUC(IM)/AUC(IV)], and the passage of the 
drug into milk (PIM), where PIM= 
AUC(milk)/AUC(serum)] (Gibaldi, 1991). 
Cefepime’s peaks concentrations in serum and 
milk (Cmax), and the time at which it was reached 
(tmax) were calculated by using the following 
formulas:  
 
Ke-Ka
Ka/Ke ln
max =C , where 
Ka is the rate constant of absorption, and Ke is 
the rate constant of elimination, and 
 
Vz
feT
maxt.Ke
max
−
= , where 
Vz is the apparent volume of distribution 
(Gibaldi, 1991) 
 
A descriptive study of the kinetic and productive 
variables was performed, and the total and partial 
correlations between such variables were 
assessed (Stell, Torrie, 1993). The kinetic 
variables, and the proteins were analysed by 
analysis of variance. The level of significance 
was 5%. 
Significant differences (P<0.05) were observed 
in the ratio of total proteins from tissue fluid in 
relation to total proteins from serum between T1 
and T2 (respectively, 83.8% and 67.5%). 
 
Daily milk productions (mean±SD) were (T1) 
IV=893±94, and IM=858±64; (T2) IV=892±75, 
and IM=796±124 ml. 
 
Serum and milk concentrations of cefepime after 
administration by IV and IM route for both 
treatments are described in Table 1. 
 
Table 1. Serum and milk concentration of 
cefepime after its intravenous (IV) and 
intramuscular (IM) administration in lactating 
goats (average of T1 and T2) 
Concentration of cefepime  (ug/ml) 
IV  IM 
Time (h) 
Serum Milk  Serum Milk 
0.25 46.25 0.25  22.6 1.25 
2 9.1 0.65  14.8 0.55 
8 0.75 0.30  0.85 0.40 
12 0.35 0.17  0.45 0.25 
 
 
Serum and milk kinetic variables of cefepinme 
administered by IV and IM routes in lactating 
goats are shown in Table 2. 
 
 
Table 2. Pharmacokinetic variables in serum (S) and milk (M) of cefepime (mean±SD) adiministered by 
intravenous (IV) and intramuscular (IM) routes (20mg/kg) to lactating goats (n=10) 
Trial 1   Trial 2  Variable IV IM  IV IM 
AUC(S) [(µg/ml)/] 98.5±16.7 57.7±12.6  68.5±33.6 95.7±38.8 
AUC(M) [(µg/ml)/h] 8.7±6.1 6.2±2.5  6.7±2.5 11.8±8.5 
Tmax (M) (h) 2.5±1.2 2.2±0.7  2.0±1.1 3.6±0.6 
Cmax (M)(µg/ml) 0.6±0.4 0.6±0.5  0.7±0.6 0.6±0.3 
Penetration (M)(%) 8.7±5.0 8.3±5.4  9.6±4.8 9.0±2.7 
AUC= areas under the curves; tmax= maximum time; Cmax= maximum concentration. 
 
 
After parenteral administration of cefepime, by 
IV and IM routes, in lactating goats, with and 
without local inflammatory reaction (using TCF 
implant), it was observed that the passage to the 
mammary gland, Cmax, tmax, and the AUC of the 
cefepime in milk were independent of route of 
administration and time of sampling.  
 
When cefepime was administered by IM route, 
its Cmax in milk was highly correlated with its 
passage to the mammary gland. Though the AUC 
in milk is independent of the moment at which 
Cmax is reached (an earlier Cmax does not 
necessarily mean a greater AUC), under IV 
conditions, significant correlations were 
observed between AUC milk and tmax (r=0.75, 
and P=0.001; r=0.97 and P=0.001, for T1 and 
T2, respectively). 
 
The times at which Cmax appeared in milk were 
correlated with cefepime’s AUC in serum after 
the IM administration (r=0.77, and P=0.001; 
r=0.59 and P=0.05, for T1 and T2, respectively). 
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It is generally accepted that Cmax is proportional 
to the amount of antibiotic that diffuses into 
milk, and tmax depends on the rate of such 
process. The AUC is proportional to the amount 
of drug that reaches the mammary gland, and is 
not related to the rate at which it enters the gland 
(Rule et al., 2000). 
 
Daily volumes of milk production, obtained 
under T1 an T2, did not show a significant 
correlation with the kinetic variables. This could 
be explained by the low volume of milk 
production of the animals employed in the 
experiment, compared to dairy cows, which 
receive another cephalosporin called ceftazidime, 
chemically related to cefepime (Rule et al., 
1996). In lactating cows, the pharmacokinetic 
profile in the serum after parenteral 
administration is different when compared to 
nonlactating cows. In lactating cows, the 
mammary gland can act as a compartment that 
traps the antibiotic in the milk. 
 
Concluding, though the penetration of cefepime 
into milk was low (less than 10%), the holding 
time for milk should be observed. The time for 
discard should be taken into account when using 
cefepime, in order to avoid problems affecting 
public health and the dairy industry. 
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RESUMO 
 
Avaliaram-se as variáveis cinéticas da cefepime e a produção de leite de cabras após a administração 
parenteral (intravenosa e intramuscular) de cefepime, com e sem reação inflamatória na região 
implantada. Dez cabras em lactação, implantadas com caixas de material sem reação imunológica para 
colher o fluido de tecido (FT) foram usadas em dois experimentos. No primeiro a aplicação de cefepime 
foi feita na primeira semana após a implantação e no segundo na oitava semana. Na primeira semana 
após a implantação observou-se elevação dos níveis de proteína no fluido do tecido após uma simples 
dose de 20mg/kg de cefepime via endovenosa ou intramuscular. Amostras do sangue e do leite foram 
obtidas e as variáveis cinéticas foram avaliadas. 
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